Puro New Zealand
Puro New Zealand is a medicinal cannabis cultivator and the only BioGro certified organic producer in Australasia. It grows and processes organic cannabis flower and extracts in Marlborough using proprietary Live Drying technology, selling to clinics, healthcare providers, and international partners in New Zealand and the UK.
- Company typePrivate
- Founded2022
- HeadquartersKaikoura, New Zealand
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Puro New Zealand does
Puro New Zealand is a privately held medicinal cannabis cultivator headquartered in Kaikōura, New Zealand, founded in 2018 and self-described as New Zealand's largest medicinal cannabis cultivator and the only BioGro certified organic producer in Australasia. The company operates two premium cultivation sites in Marlborough — an award-winning outdoor organic farm and manufacturing facility producing high THC, CBD and minor cannabinoid flower and solventless extract material, and a specialised indoor research and breeding facility at Waihopai — together with a coastal growing site at Kēkerengū near Kaikōura. Its processing pipeline centres on a proprietary "Live Drying" seven-stage method (peak harvest, flash freezing, cryo-trimming, freeze drying, precision trimming, controlled curing, packaging) that the company claims preserves cannabinoids, terpenes, and flavonoids more completely than conventional drying.
Its products include the Kākāriki Koha 'Green Gift' high-THC cultivar and the Ultra Pink CBD cultivar, both developed in-house through a genetics program that emphasises phenotyping and trait-assisted breeding. Revenue is generated by selling organic medicinal cannabis flower and extracts through clinic and patient access partnerships in New Zealand (with named channel partners including LTD Labs, Cannatrek, Helios, IPS Pharma, MOCA Health AU, and RUA) and through international manufacturing agreements — most notably a three-year deal with Epsilon Pharma to produce finished formulations for the UK market, expected to generate USD 6 million in manufacturing revenue. The company was capitalised in April 2022 by a NZD 32 million package combining NZD 13 million in public funding from the New Zealand government with NZD 19 million from private investors, projected to create up to 200 jobs and support agricultural diversification. Disclosed headcount today is 1-10, and the company has earned a Supreme Award for its organic cultivation operations.
Puro New Zealand firmographics
Firmographics- Name
- Puro New Zealand
- Legal name
- Puro New Zealand
- Website
- https://puro.co.nz
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Puro New Zealand is a medicinal cannabis cultivator and the only BioGro certified organic producer in Australasia. It grows and processes organic cannabis flower and extracts in Marlborough using proprietary Live Drying technology, selling to clinics, healthcare providers, and international partners in New Zealand and the UK.
- Ownership category
- akta.pro rank
Where Puro New Zealand is headquartered
LocationHeadquarters
- HQ city
- Kaikoura
- HQ country
- New Zealand
- HQ region
- Oceania
Offices3 records
Markets served
Puro New Zealand business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Supply Chain, Personnel, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Medicinal Cannabis Products: Puro generates revenue from cultivating and selling organic medicinal cannabis products including high THC, CBD and minor cannabinoid flower and solventless extract material. Products are distributed throughout New Zealand and internationally.
- UK Manufacturing Partnership: Manufacturing agreement with Epsilon Pharma for finished formulation products for the UK market, expected to generate $6 million in manufacturing revenue over an initial three-year period.
Go-to-market motion1 record
Distribution channels4 records
Marketing channels5 records
Puro New Zealand product offering
Product offeringCore offering
Puro New Zealand cultivates and manufactures organic medicinal cannabis — including high-THC, CBD, and minor cannabinoid flower plus solventless extract material — across two Marlborough cultivation sites and sells these to healthcare clinics, patient access providers, and international manufacturing partners. The company differentiates through its proprietary Live Drying processing technology and BioGro certified organic production, delivering consistent, high-purity medicinal cannabis products such as the Kākāriki Koha and Ultra Pink cultivars.
Product overview
Puro New Zealand is New Zealand's largest medicinal cannabis cultivator offering a portfolio of organic cannabis products. The company operates two premium cultivation sites in Marlborough: an award-winning organic outdoor farm and manufacturing facility producing high THC, CBD and minor cannabinoid flower and solventless extract material, and an indoor specialized research and breeding facility at Waihopai for developing novel New Zealand varieties. Key products include Kākāriki Koha 'Green Gift' (a high-THC medicinal flower) and Ultra Pink (a CBD cultivar). The company differentiates through its Live Drying Technology—a seven-stage proprietary processing innovation—and as the only BioGro certified organic producer in Australasia. Products are distributed through clinic and patient access partnerships throughout New Zealand and internationally.
Differentiator
Problem solved
Functional benefit
Brands
- Kākāriki Koha: Unique medicinal flower developed by research and breeding team at Waihopai facility, a high-THC cultivar with complex aromatic profile.
- Ultra Pink
Products and services
- Kākāriki Koha 'Green Gift' A unique high-THC medicinal cannabis flower developed at Puro's Waihopai research and breeding facility, with a complex aromatic profile and industry-leading phenotyping and trait-assisted breeding protocols. Marketed as setting a new benchmark for purity and efficacy for patients treating conditions such as anxiety, pain, and sleep disorders.
- Ultra Pink A visually distinctive CBD-dominant medicinal cannabis cultivar developed through five years of meticulous breeding and grown organically at Puro's coastal Kēkerengū farm. Targeted at medicinal cannabis patients seeking CBD-dominant therapy for anxiety, pain, and sleep disorders.
Quantifiable outcome
- Live drying enables faster processing and eliminates bottlenecks while delivering consistent quality without variations between drying racks
- +2 more outcomes
Companies that use Puro New Zealand
Customer profileNamed customers6 records
Segments3 records
Ideal customer profiles3 records
Puro New Zealand technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Puro New Zealand partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core and minor.
- LTD LabscoreClinic and patient access partner for Puro's medicinal cannabis products.
- CannatrekcoreClinic and patient access partner for Puro's medicinal cannabis products.
- HelioscoreClinic and patient access partner for Puro's medicinal cannabis products.
- IPS PharmacoreClinic and patient access partner for Puro's medicinal cannabis products.
- MOCA Health AUcoreClinic and patient access partner for Puro's medicinal cannabis products in Australia.
- RUAcoreClinic and patient access partner for Puro's medicinal cannabis products.
- New Zealand Ministry of HealthminorGovernment network partner providing regulatory oversight and support for medicinal cannabis industry in New Zealand.
- New Zealand Medicinal Cannabis Council (NZMCC)minorIndustry body partner supporting the development and standards of New Zealand's medicinal cannabis industry.
- New Zealand Trade and Enterprise (NZTE)minorGovernment's international business development agency supporting Puro's global growth initiatives, including participation in events like The NZ Room in London.
- Ministry for Primary Industries (MPI)minorGovernment partner providing primary industry support and regulatory oversight.
Scale indicators5 records
Recent moves6 records
Expansion highlights6 records
Puro New Zealand competitors and assessment
Company assessmentRegional players
- Little Green Pharma: Australian medicinal cannabis cultivator and manufacturer with EU export operations; comparable model but primarily serving Australia/Europe.
- Althea Group: Australia-based medicinal cannabis producer and distributor serving patients via clinics, similar B2B/patient-access model in an adjacent geography.
- Cann Group: Australian cultivator of medicinal cannabis with R&D and breeding focus, comparable cultivation/genetics model in a neighboring market.
Direct peers
- Helius Therapeutics: New Zealand-based licensed medicinal cannabis cultivator and manufacturer; a direct domestic competitor in cultivation and patient supply.
- Rua Bioscience: NZX-listed New Zealand medicinal cannabis company cultivating and supplying products to clinics and patients, directly comparable in market and model.
- Cannasouth: New Zealand cannabis cultivation and research company producing medicinal cannabis, competing in the same domestic regulatory and patient-access space.
- Eqalis: New Zealand medicinal cannabis grower and product developer supplying patients and clinics, a direct domestic peer.
- Greenfern Industries: NZ medicinal cannabis cultivator focused on sustainable/organic production, closely aligned with Puro's organic, eco-positioned cultivation approach.
Broad incumbents
- Bedrocan: Established European medicinal cannabis cultivator known for standardized pharmaceutical-grade flower, an incumbent in the medical-grade cultivation niche Puro targets.
- Tilray Brands: Large global cannabis company with cultivation, manufacturing and international medical distribution; a broad incumbent overlapping Puro's medicinal cannabis category.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Puro New Zealand social profiles
Digital presencePuro New Zealand compliance and trust
Trust signalCompliance1 record
Puro New Zealand financial estimates
Financial estimateRevenue estimate
Valuation estimate
Puro New Zealand leadership team
Management profileNumber of profiles
Profiles3 records
Puro New Zealand funding detail
Funding detailFunding overview
Funding rounds2 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Puro New Zealand M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Puro New Zealand
What does Puro New Zealand do?
Puro New Zealand cultivates and manufactures organic medicinal cannabis — including high-THC, CBD, and minor cannabinoid flower plus solventless extract material — across two Marlborough cultivation sites and sells these to healthcare clinics, patient access providers, and international manufacturing partners. The company differentiates through its proprietary Live Drying processing technology and BioGro certified organic production, delivering consistent, high-purity medicinal cannabis products such as the Kākāriki Koha and Ultra Pink cultivars.
Is Puro New Zealand a public or private company?
Puro New Zealand is a private company. It is classified as unknown and is currently operating.
When was Puro New Zealand founded?
Puro New Zealand was founded in 2022. It employs 1 to 10 people.
Where is Puro New Zealand based?
Puro New Zealand is headquartered in Kaikoura, New Zealand, in the Oceania region.
How does Puro New Zealand make money?
Two revenue lines are on record. Medicinal Cannabis Products are the primary driver. The others are UK Manufacturing Partnership.
Who are Puro New Zealand's main competitors?
Regional players on record are Little Green Pharma, Althea Group and Cann Group. Direct peers are Helius Therapeutics, Rua Bioscience, Cannasouth, Eqalis and Greenfern Industries. Broad incumbents are Bedrocan and Tilray Brands.
Does Puro New Zealand have an API?
No public API is recorded for Puro New Zealand.